Clinical Trial Update: Retrospective Data Review of ReCap Total Hip Resurfacing

View source ↗

Summary

A retrospective data review trial evaluating the ReCap Total Hip Resurfacing for osteoarthritis of the hip has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• ReCap Total Hip Resurfacing

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis of the Hip | Status: WITHDRAWN